American University of Health Sciences, with the Southern California Chapter of the ACRP, held an end-of-the-year virtual event to inform and educate healthcare professionals about COVID-19 and the effects that it has on clinical and non-clinical studies. This is the university’s second collaboration and partnership with the chapter this year. The event, titled “COVID-19 & The Effect on Clinical/Non-Clinical Studies”, was held on December 9, 2020 and was a two-hour virtual event that discussed about FDA guidelines and protocols to take during the ongoing pandemic, such as re-envisioning clinical trials, how to ensure participant safety, and increasing feasibility of clinical and non-clinical studies in times of crisis. Mr. Eric Pittman, the current Program Division Director for the FDA/ORA Bioresearch Monitoring Program Division II (BIMO-W), was once again the guest speaker for this event as highlights and points of discussion were informed during his presentation. AUHS, along with the Southern California Chapter of the ACRP, firmly believes that providing and educating about the proper steps and measures to take regarding clinical and non-clinical studies are imperative within FDA and healthcare regulations. The university is proud of hosting this event and many more upcoming quarterly events regarding the FDA.